Method for synthesizing (4R, 5R)-1-acetyl-2, 4, 5-triphenyl-4, 5-dihydroimidazole
The preparation of high purity (4R,5R)-1-acetyl-2,4,5-triphenyl-4 in the prior art was solved by selective hydrolysis reaction using lipase catalyst and PBS buffer in organic solvents. ,5-dihydroimidazole has high cost and difficulty in purification, and realizes the preparation of high-purity products and environmentally friendly process flow.
Patent Information
- Application Number
- CN202411375016.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art faces high costs, difficulty in product purification and difficulty in recycling chemical splitters when preparing high purity (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazoles The problem.
Using lipase as a catalyst to perform selective hydrolysis in an organic solvent, using PBS as a buffer, and by controlling reaction conditions such as temperature and time, (4R,5R)-1-acetyl-2,4,5- is gradually isolated from (4R,5R)-1-acetyl-2,4,5- Triphenyl-4,5-dihydroimidazole and (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole.
It reduces the use of waste acid and wastewater, improves the optical purity of the product, simplifies the operation process, reduces environmental pollution, and the recycling of lipase is safe and reliable.
Smart Images

Figure QLYQS_1 
Figure BDA0005068462110000021 
Figure BDA0005068462110000022
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of fine chemicals, and in particular relates to a method for synthesizing (4R, 5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole by efficient selective hydrolysis with the participation of lipase. Background Art
[0002] Optically active 1,2-diphenylethylenediamine is an important reagent with C2-symmetric chirality, which is used in many fields such as medicine, life sciences, pesticides, dyes, etc. (CN86100815, CN202011177578.6). As researchers conduct in-depth research on the properties and applications of optically pure diphenylethylenediamine, its application potential in new energy, new materials and other fields is gradually being explored. For example, Li Rui pointed out in her paper "Synthesis of Chiral Amphiphilic Small Molecule Compounds Based on Cyclohexanediamine and 1,2-Diphenylethylenediamine and Their Application in the Preparation of Nanomaterials" that diphenylethylenediamine can be used to prepare new polymer nanoconductive materials, providing new ideas and directions for the development of new energy and new materials.
[0003] Chen Weiping et al. reported the synthesis of high-purity (1R,2R)-diphenylethylenediamine in the Chinese Journal of Pharmaceutical Industry and Braddock et al. reported in Tetrahedron: Asymmetry. There are two main methods, among which (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole is a very important intermediate, and its content directly determines the quality of the (1R,2R)-diphenylethylenediamine product. Compared with the two methods in the literature, method 1 adopts the method of synthesis followed by splitting, which faces a series of problems such as high cost and difficulty in product purification; while method 2 adopts the method of splitting before synthesis, first preparing (4R,5R)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole by chemical splitting, then synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole by acylation reaction, and then synthesizing (1R,2R)-diphenylethylenediamine by subsequent reaction. This method has low cost and the product is easier to purify, but it requires multiple splitting and purification, the chemical splitting agent used is difficult to recover, and the amount of solvent and wastewater is large; the above two different methods are expressed by reaction equations as follows:
[0004]
[0005] Therefore, it is of great significance to find a method for preparing high-purity (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole. Summary of the invention
[0006] The object of the present invention is to provide a method for preparing high-purity (4R, 5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole.
[0007] Specifically, the method for preparing high-purity (4R, 5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole of the present invention comprises the following steps:
[0008]
[0009] In an organic solvent, with lipase as a catalyst and PBS as a buffer reagent, the racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole is selectively hydrolyzed and precipitated in an organic solvent after cooling to obtain (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole and (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole.
[0010] Furthermore, in the above technical solution, the organic solvent is selected from toluene, methyl tert-butyl ether, dichloromethane or ethyl acetate.
[0011] Furthermore, in the above technical solution, the lipase is hydrophobic immobilized lipase Novozyme 435.
[0012] Furthermore, in the above technical solution, PBS is 0.2 mol / L phosphate buffer, pH=7.0; the mass ratio of racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole to PBS is 0.05-0.40:1; preferably 0.10-0.30:1.
[0013] Furthermore, in the above technical solution, the mass ratio of lipase to racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole is 0.005-0.20:1; preferably 0.01-0.10:1.
[0014] Furthermore, in the above technical solution, the mass ratio of the racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole to the organic solvent is 1:8-20; preferably 1:10-15.
[0015] Further, in the above technical solution, the reaction temperature is 20-80°C, preferably 30-50°C;
[0016] Furthermore, in the above technical solution, the reaction time is 18-40h, preferably 24-30h.
[0017] Further, in the above technical scheme, the typical reaction operation is as follows: to a four-necked reaction bottle with a stirrer and a thermometer sleeve, toluene, racemic (±)-(4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, Novozyme 435 lipase and buffer PBS, after adding, keep warm and stir for 24 hours; filter the obtained reaction solution to recover the lipase; separate the obtained filtrate while hot; cool the obtained organic layer to room temperature and filter under reduced pressure, rinse the filter cake with solvent, dry the filter cake to obtain compound (4R, 5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, combine the rinsing liquid and the filtrate and desolvate under reduced pressure; add ethyl acetate to the desolvated material, heat to 50-55°C and stir for 1 hour, slowly cool to 0-5°C, keep warm and filter under reduced pressure, dry the filter cake to obtain compound (4S, 5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole.
[0018] Advantageous Effects of the Invention
[0019] 1. The present invention reduces the problem of more waste acid and waste water in the traditional route.
[0020] 2. The separation method provided by the present invention has readily available raw materials, simple operation, high optical purity of the product, no obvious inactivation of the lipase after 11 cycles, and is safe, has little harm to the human body, and light environmental pollution. DETAILED DESCRIPTION
[0021] The following examples may enable those skilled in the art to more fully understand the present invention, but are not intended to limit the present invention in any way.
[0022] Comparative Example
[0023] In a 1000mL four-necked bottle, 500mL of toluene and 42g (0.12mol, SS:RR=1:1.1, i.e., RR content of 52.38%) of racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole were added in sequence, the temperature was raised to 40-50°C in the kettle until the materials in the kettle were dissolved, the mixture was stirred for 2h at this temperature, the temperature was slowly lowered to 10-20°C, stirred for 0.5h at this temperature, and the mixture was filtered under reduced pressure at this temperature. The filter cake was rinsed with ice toluene and dried to obtain 31g of racemic (±)-(4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, with a liquid phase normalized content of 99.05% and an RR content of 53.50%.
[0024] Example 1
[0025] In a 1000mL four-necked bottle, 500mL of toluene, 42g (0.12mol, SS:RR=1:1.1, i.e., RR content of 52.38%) of racemic (±)1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole), 1.20g of Novozyme 435 lipase and 200g of PBS were added in sequence, and then the temperature was raised to 40-50°C and stirred for 24h, the lipase was filtered out, and the layers were separated while hot, the organic layer was slowly cooled to 10-20°C, stirred for 0.5h, filtered under reduced pressure, the filter cake was rinsed with ice toluene, and dried to obtain 19.8g of compound (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, with a liquid phase normalized content of 99.21%, an optical purity of 99.04%, and a yield of 94.28%. The filtrate and the eluent were combined, desolvated under reduced pressure, 60 g of ethyl acetate was added, the temperature was raised to 50-55°C, stirred for 1 h, the temperature was slowly lowered to 0-5°C, stirred for 0.5 h, filtered under reduced pressure, and the filter cake was dried to obtain 17.1 g of compound (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole.
[0026] Example 2
[0027] In a 1000mL four-necked bottle, 500mL of methyl tert-butyl ether, 42g (0.12mol, SS:RR=1:1.1, i.e., RR content of 52.38%) of racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole), 1.20g of Novozyme 435 lipase and 200g of PBS were added in sequence, and then the temperature was raised to 40-50°C and stirred for 24h, the lipase was filtered out, and the layers were separated while hot, the organic layer was slowly cooled to 10-20°C, stirred for 0.5h, filtered under reduced pressure, the filter cake was rinsed with ice methyl tert-butyl ether, and dried to obtain 19.1g of compound (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, with a liquid phase normalized content of 99.01%, an optical purity of 98.24%, and a yield of 90.95%. The filtrate and the eluent were combined, desolvated under reduced pressure, 60 g of ethyl acetate was added, the temperature was raised to 50-55°C, stirred for 1 h, the temperature was slowly lowered to 0-5°C, stirred for 0.5 h, filtered under reduced pressure, and the filter cake was dried to obtain 17.6 g of compound (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole.
[0028] Example 3
[0029] In a 1000mL four-necked bottle, 500mL of dichloromethane, 42g (0.12mol, SS:RR=1:1.1, i.e., RR content of 52.38%) of racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole), 1.80g of Novozyme 435 lipase and 200g of PBS were added in sequence, and then the temperature was raised to 30-40°C and stirred for 40h, the lipase was filtered out, and the layers were separated while hot, the organic layer was slowly cooled to 10-20°C, stirred for 0.5h, filtered under reduced pressure, the filter cake was rinsed with ice dichloromethane, and dried to obtain 17.1g of compound (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, with a liquid phase normalized content of 98.91%, an optical purity of 98.06%, and a yield of 81.42%. The filtrate and the eluent were combined, desolvated under reduced pressure, 60 g of ethyl acetate was added, the temperature was raised to 50-55°C, stirred for 1 h, the temperature was slowly lowered to 0-5°C, stirred for 0.5 h, filtered under reduced pressure, and the filter cake was dried to obtain 17.3 g of compound (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole.
[0030] Example 4
[0031] In a 500mL four-necked bottle, 1000mL of ethyl acetate, 42g (0.12mol, SS:RR=1:1.1, i.e., RR content of 52.38%) of racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole), 1.60g of Novozyme 435 lipase and 200g of PBS were added in sequence, and then the temperature was raised to 40-50°C and stirred for 30h, the lipase was filtered out, and the layers were separated while hot, the organic layer was slowly cooled to 10-20°C, stirred for 0.5h, filtered under reduced pressure, the filter cake was rinsed with glacial ethyl acetate, and dried to obtain 17.5g of compound (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, with a liquid phase normalized content of 98.83%, an optical purity of 98.17%, and a yield of 83.33%. The filtrate and the eluent were combined, desolvated under reduced pressure, 60 g of ethyl acetate was added, the temperature was raised to 50-55°C, stirred for 1 h, the temperature was slowly lowered to 0-5°C, stirred for 0.5 h, filtered under reduced pressure, and the filter cake was dried to obtain 17.0 g of compound (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole.
[0032] The above are only preferred embodiments of the present invention. It should be noted that the above preferred embodiments should not be regarded as limiting the present invention, and the protection scope of the present invention should be based on the scope defined by the claims. For ordinary technicians in this technical field, several improvements and modifications can be made without departing from the spirit and scope of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention.
Claims
1. A method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole, using lipase to selectively hydrolyze secondary amines; characterized in that: The steps include: In an organic solvent, with lipase as a catalyst and PBS as a buffer reagent, the racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole is selectively hydrolyzed and precipitated in an organic solvent after cooling to obtain (4S,5S)-4,5-dihydro-2,4,5-triphenyl-1H-imidazole and (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole.
2. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: The organic solvent is selected from toluene, methyl tert-butyl ether, dichloromethane or ethyl acetate.
3. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: The lipase is hydrophobic immobilized lipase Novozyme 435.
4. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: PBS is a 0.2 mol / L phosphate buffer solution, pH=7.0; the mass ratio of racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole to PBS is 0.05-0.40:1, preferably 0.10-0.30:
1.
5. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: The mass ratio of lipase to racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole is 0.005-0.20:1, preferably 0.01-0.10:
1.
6. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: The mass ratio of the racemic (±)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole to the organic solvent is 1:8-20, preferably 1:10-15.
7. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: The reaction temperature is 20-80°C, preferably 30-50°C.
8. The method for synthesizing (4R,5R)-1-acetyl-2,4,5-triphenyl-4,5-dihydroimidazole according to claim 1, characterized in that: The reaction time is 18-40h, preferably 24-30h.
